This website is only applicable outside of the Americas and Europe.
Renew Enhanced Circulation Logo
Medical

Cardiac Effects

Benefits for the Heart

Renew™ ECP therapy provides significant cardiac benefits, supporting heart health and circulation.

cardiac benefits
Reduced Angina Class:

After ECP treatment, 71 out of 101 patients showed improvement of ≥1 CCS angina class, and 33 patients improved by ≥2 CCS classes. Patients with ANOCA experienced reduced angina and improved physical capacity.


Reduced Preload:

Decreased ventricular stretching during diastole, easing the heart’s workload.


Lowered Myocardial Oxygen Demand:

Minimises the heart’s oxygen needs for optimal function.


Enhanced Coronary Blood Flow:

Increases blood flow to the heart muscle, improving myocardial perfusion.

Peripheral Effects

Benefits to the Blood Vessels

Renew™ ECP therapy enhances blood vessel health and improves peripheral circulation.

Increased Nitric Oxide Production:

Promotes vasodilation and reduces vascular resistance.


Promotion of Angiogenesis:

Facilitates new blood vessel development, improving tissue perfusion.


Vasodilation:

Relaxes vascular smooth muscle, enhancing blood flow.


Enhanced Tissue Perfusion:

Improves blood flow to tissues and organs.

blood vessel benefits

Proven Patient Benefits

Real Results: Proven Patient Outcomes

ECP therapy delivers real results, with proven improvements in patient health and quality of life.

patient benefits
Increased Energy:

Boosts energy levels and reduces fatigue.


Enhanced Activity:

Improves exercise tolerance and reduces myocardial ischemia in coronary artery disease.


Improved Cardiovascular Fitness:

Supports sustained physical activity without symptoms.


Long-Term Benefits:

Provides lasting benefits for up to two years, with repeatable therapy.

References

  1. Yang, D.Y. and G.F. Wu, Vasculoprotective properties of enhanced external counterpulsation for coronary artery disease: beyond the hemodynamics. Int J Cardiol, 2013. 166(1): p. 38-43.
  2. Loh, P.H., et al., Enhanced external counterpulsation in the treatment of chronic refractory angina: a long-term follow-up outcome from the International Enhanced External Counterpulsation Patient Registry. Clin Cardiol, 2008. 31(4): p. 159-64.
  3. Feldman, A.M., et al., Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol, 2006. 48(6): p. 1198-205.
  4. Abbottsmith, C. W., et al., Enhanced external counterpulsation improves exercise duration and peak oxygen consumption in older patients with heart failure: a subgroup analysis of the PEECH trial. Congest Heart Fail, 2006. 12(6), p. 307-311.
  5. Martin, J.S., et al., Enhanced external counterpulsation improves peripheral artery function and glucose tolerance in subjects with abnormal glucose tolerance. J Appl Physiol (1985), 2012. 112(5): p. 868-76.
  6. Martin, J.S. and R.W. Braith, Anti-inflammatory effects of enhanced external counterpulsation in subjects with abnormal glucose tolerance. Appl Physiol Nutr Metab, 2012. 37(6): p. 1251-5.
  7. Campbell, A.R., et al., Enhanced external counterpulsation improves systolic blood pressure in patients with refractory angina. Am Heart J, 2008. 156(6): p. 1217-22.
  8. Casey, D.P., et al., Effects of enhanced external counterpulsation on arterial stiffness and myocardial oxygen demand in patients with chronic angina pectoris. Am J Cardiol, 2011. 107(10): p. 1466-72.
  9. Braverman, D.L., et al., The safety and efficacy of enhanced external counterpulsation as a treatment for angina in patients with aortic stenosis. Clin Cardiol, 2013. 36(2): p. 82-7.
  10. Lin, W., et al., Predictors of good functional outcome in counterpulsation-treated recent ischaemic stroke patients. BMJ Open, 2013. 3(6).
  11. Han, J.H., et al., Preliminary findings of external counterpulsation for ischemic stroke patient with large artery occlusive disease. Stroke, 2008. 39(4): p. 1340-3.
  12. Applebaum, R.M., et al., Sequential external counterpulsation increases cerebral and renal blood flow. Am Heart J, 1997. 133(6): p. 611-5.
  13. Werner, D., et al., Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis. Nephrol Dial Transplant, 2005. 20(5): p. 920-6.
  14. Froschermaier, S.E., et al., Enhanced external counterpulsation as a new treatment modality for patients with erectile dysfunction. Urol Int, 1998. 61(3): p. 168-71.
  15. Lawson, W.E., et al., Effect of enhanced external counterpulsation on medically refractory angina patients with erectile dysfunction. Int J Clin Pract, 2007. 61(5): p. 757-62.
  16. Lawson, W.E., J.C. Hui, and P.F. Cohn, Long-term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up study. Clin Cardiol, 2000. 23(4): p. 254-8.
  17. Braith, R.W., et al., Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study. Circulation, 2010. 122(16): p. 1612-20.
  18. Werner, D., et al., Pneumatic external counterpulsation: a new noninvasive method to improve organ perfusion. Am J Cardiol, 1999. 84(8): p. 950-2, A7-8.